Make your money go further for just 25p per day

Novartis (NOVN)

· Sector: Pharmaceuticals & Biotechnology

PREMIUM
Portfolio

Mega-Trends: A troubling 2021 opens opportunities for recovery

11/02/2022
Pharma, renewables and China hurt the Mega-Trends portfolio but there is still plenty of innovation to go around

More on Novartis


PREMIUM
Portfolio

Mega-Trends Portfolio: CRISPR is the future

17/03/2021
PREMIUM
Portfolio

CRISPR: one of the most important inventions of the century?

15/01/2021
PREMIUM
Portfolio

How to profit from advances in genetic medicine

24/10/2019

Sign-up to our free email updates

SIGN UP